and fluids. 2 As a result, LD serum activity can be altered in disease states. Urine, effusions, and cerebrospinal fluid (CSF) can exhibit changes in LD activity secondary to cellular damage. 3 Studies in both human and veterinary patients have found total LD activity and isoenzyme distribution to be clinically useful. Serum LD activities have been used as diagnostic and prognostic indicators for both systemic and localized diseases in human medicine, including malignancies such as lymphoma and leukemia. [4] [5] [6] [7] [8] As in people, canine serum LD concentrations may be used as a prognostic tool in lymphoma cases. [9] [10] [11] In addition, serum LD levels have been demonstrated to be significantly elevated in dogs with metastatic mammary tumors. 12 Moreover, variations in LD activity can help characterize effusions by differentiating transudates and exudates in both veterinary and human patients. 13 However, the diagnostic significance of serum LD remains relatively unexplored in veterinary medicine, and there are few published studies describing the normal activity of serum LD and its isoenzymes in dogs. 9, 14, 15 Cerebrospinal fluid LD activity and isoenzyme patterns have also proven clinically relevant in human medicine. Studies have found that LD isoenzyme distributions in the CSF can rapidly differentiate bacterial meningitis from aseptic meningitis in human patients, [16] [17] [18] [19] and that CSF isoenzymes are altered in patients with Guillain-Barre syndrome 20 and multiple sclerosis. 21 Importantly, there have been very few studies regarding CSF LD activity in veterinary medicine, although there are indications that it could be a useful diagnostic tool for distinguishing between neurologic diseases that present similarly, such as infectious and noninfectious meningitis. [22] [23] [24] [25] Moreover, the normal activity and distribution of LD and its isoenzymes in canine CSF have been poorly characterized, with only 1 study of Beagles currently described in the literature. 14 To investigate future clinical applications of LD in veterinary medicine, this study first seeks to clarify and establish the activity and distribution of LD and its isoenzymes in the serum and CSF of healthy dogs. By establishing an RI for this enzyme in dogs, the present study forms the basis for further study of the diagnostic and prognostic applications of LD in systemic and neurologic diseases in canines.
| MATERIALS AND METHODS

| Study design
Healthy dogs undergoing elective anesthesia at the Washington State University Veterinary Teaching Hospital (WSU-VTH) were recruited to participate in this study. American Society of Veterinary Clinical Pathologists (ASVCP) guidelines were utilized in the development of the study design and analysis. 26, 27 Due to the inherent risks of CSF collection, the goal was to attain the minimum number of participants required to establish an appropriate RI while minimizing risk to healthy dogs. 26, 27 At least 40 reference individuals were enrolled for each RI (serum total LD, n = 41; serum isoenzymes, n = 40; CSF total LD, n = 40; CSF isoenzymes, n = 42) to perform nonparametric statistics, as enzymes often have non-Gaussian distributions. 28 This study received approval from Washington State University's Institutional Animal Care and Use Committee and met all institutional standards.
| Sample group
Dogs were considered eligible for the study if they were undergoing anesthesia for an elective procedure such as spay/neuter, dental prophylaxis, or orthopedic surgery. Dogs were either client-owned or recruited from local animal shelters. Client consent and general health history were obtained for each patient prior to enrollment in the study. A thorough physical examination and neurologic evaluation were performed by a board-certified veterinary neurologist before samples were collected. Venous blood and CSF obtained from the atlanto-occipital space were collected under isoflurane anesthesia prior to surgery and were promptly submitted for laboratory analysis to detect any hematologic or cytologic abnormalities. interfere with the quantification of total LD activity. 35 Dogs with an icterus (I) index value >1 were also excluded from the study.
| Inclusion criteria
| Serum and cerebrospinal fluid collection
Serum for LD analysis was obtained from 1 mL of venous blood that was allowed to clot for 15 minutes before centrifugation. About 100 lL of serum was used to analyze total LD activity, and another 100 lL of serum was used for LD isoenzyme analysis.
Approximately 2 ml of CSF was collected via the atlanto-occipital space after the dog was anesthetized, although in some cases less than 1 mL of CSF was obtainable due to small patient size or slow flow rate. Of this, 0.5-1 mL of CSF was submitted for cytology and determination of fresh values of total CSF LD (requiring 100 lL).
About 100 lL of CSF reserved for isoenzyme analysis was ultrafiltrated with a 50 kDa Amicon filter (Amicon Ultra-0.5, Millipore, Billerica, MA, USA) at 14 000g for 10 min to a final volume of 20 lL for isoenzyme analysis, as previously described. 35 Where a limited volume of CSF was available after cytologic analysis, 100 lL was either used for total LD determination or isoenzyme determination.
Similarly, if an insufficient quantity of serum was available, 100 lL was used for either total LD determination or isoenzyme analysis.
Total LD and isoenzyme activity were measured within 8 hours 
| Cerebrospinal fluid analysis
| Total LD determination
Serum and CSF total LD activities were determined spectrophotometrically using Siemens Dimension Xpand (analytic range: 6-1000 U/L for both serum and CSF). In this assay, L-lactate is oxidized in the presence of nicotinamide adenine dinucleotide (NAD   +   ) by LD, producing pyruvate and the reduced form of NAD + (NADH). The LD concentration was determined by a rate reaction at 340/700 nm, where 340 nm is the wavelength absorbed by NADH. Our laboratory previously established intra-assay (within-run) confidence intervals (CVs)
for serum and CSF total LD as 3.9% and 13.2%, respectively, using 34 serum triplicate data points and 60 CSF triplicate data points from healthy dogs. 36 Intra-assay CVs were calculated by determining the ratio of the SD to the mean for each response variable mean from the triplicate data points. 37 Due to the labile nature of LD 38 , inter-assay (between-run) CVs are difficult to measure accurately, as LD degrades rapidly with storage. Using optimal storage temperatures for LD retention (À20°C) 36 , our lab approximated inter-assay CVs using serum from 5 dogs and ultrafiltrated CSF from 6 dogs measured in triplicate at 0, 24, 48, and 72 hours after collection. Serum total LD ranged from 19-135 U/L, and CSF total LD ranged 6-27 U/L. Inter-assay CV was calculated by determining the mean ratio of the SD of the sample means to the mean of the sample total LD values. 37 Serum and CSF total LD inter-assay CVs were 3.1% and 15.4%, respectively.
| Electrophoresis and densitometric scanning
Serum and ultrafiltrated CSF were electrophoresed using Helena
Laboratories QuickGel LD Isoenzyme Kit and QuickGel Chamber (Beaumont, TX, USA) as previously described. 36 Briefly, 2 lL of each sample was applied to multiple lanes, and at least 2 control lanes were run on each gel ( 26, 27 Outliers were detected using Dixon's outlier range statistic. 26 For data with a Gaussian distribution, the robust method was used to establish RIs and 90% confidence intervals (CIs). Parameters with nonnormal distributions were transformed using the Box-Cox method, and for those that were successfully transformed, robust methods were used to establish RIs and 90% CIs. Ranges that did not have a Gaussian distribution and could not be transformed were calculated via the nonparametric method and 90% CIs were F I G U R E 1 Linear regression analysis demonstrates that measuring total lactate dehydrogenase (LD) up to 240 min after collection and LD isoenzymes up to 430 min after collection does not significantly affect total LD activity nor isoenzyme percentages prepared with the bootstrap method. 90% CIs were calculated for all RIs as recommended by the ASVCP guidelines.
| Statistical analysis
26,27
3 | RESULTS Seventy-four dogs were initially recruited for the study. Seven dogs were excluded because of CBC or serum biochemistry abnormalities. Of the remaining dogs with unremarkable bloodwork, 16 had H > 2 on the HIL index due to iatrogenic hemolysis, resulting in exclusion from the serum total LD and serum LD isoenzyme RIs.
However, dogs with H > 2 were still considered eligible to be included in the CSF RIs.
The same dogs did not comprise all RIs, as iatrogenic hemolysis and insufficient sample quantity excluded some dogs from certain RIs. When insufficient volumes were available, samples were allocated to either the total LD (serum, n = 5; CSF, n = 7) or isoenzyme (serum, n = 4; CSF, n = 9) RIs. Thirty-six dogs were included in both serum total and isoenzyme RIs; 33 dogs were included in both CSF total and isoenzyme RIs. 20 healthy dogs with H ≤ 2 had sufficient serum and CSF volumes to be included in all RIs.
Two dogs had percentages that were outliers according to Dixon's method in 1 or more of the 5 serum LD isoenzymes, and data from these dogs were excluded from all serum isoenzyme RIs.
In total, 41 clinically healthy dogs were included in the serum total LD RI, and 40 dogs comprised the CSF total LD RI. Serum and CSF LD isoenzyme RIs were made up of 40 and 42 clinically healthy dogs, respectively. Population data are presented in Table 1 and breed data are presented in Table 2 .
For samples from dogs where time-to-analysis was reported, mean time from collection to analysis of total LD was 100 minutes, and for isoenzyme analysis, the mean time-to-analysis was 165 minutes. The mean serum total LD value for dogs included in this study was 70.8 U/L, with LD-5 contributing the greatest fraction of this value. RIs for serum total LD and serum LD isoenzymes are presented in Tables 3 and 4 , respectively.
T A B L E 1 Population statistics for each RI
The mean CSF total LD value was 10.0 U/L. LD-1 was the predominant isoenzyme in the CSF, followed by LD-2. RIs for CSF total LD and CSF LD isoenzymes are presented in Tables 3 and 5 , respectively.
| DISCUSSION
This study is foundational for future investigations of this enzyme and its clinical use in veterinary medicine. Prior to this study, there have been a limited number of reports describing the activity of LD and its isoenzymes in canine serum and CSF. 9, 14, 15 Our laboratory found that in canine serum, the mean total LD value was nearly 7 times that of the total LD value in the CSF (Table 3 ). The fact that serum LD activity is much higher than CSF LD activity correlates with other studies in both dogs and people. 9,14,15 A 1986 study of 26 Beagles reported that mean serum total LD was 64.50 AE 7.447 IU, while mean CSF total LD was 4.51 AE 0.524 IU. 14 The total LD activities found in our study demonstrate wider variability. It is probable that the age, breed, and historical diversity-along with the increased number of animals in our sample population-contributed to wider reference ranges for both serum and CSF LD activities, which are likely more representative of the greater population.
Serum LD isoenzyme percentages have also been previously reported for dogs (Table 6 ). Heavner et al found that serum LD-5 was predominant, followed by LD-4, LD-3, LD-1, and finally LD-2.
14 Another study of 8 dogs described similar serum LD isoenzyme percentages, where LD-5 > LD-4 > LD-3 > LD-2 > LD-1. 14 In comparison, we found that LD-5 accounted for the greatest percentage of serum LD, contributing over half of the total, followed by LD-1, roughly equal quantities of LD-3 and LD-4, and finally LD-2. Our findings correlate with a more recent study that reported similar percentages of serum LD isoenzymes from the sera of 16 healthy dogs. 9 The reason for this discrepancy is likely multi-factorial. Studies, including our own, have shown that LD isoenzymes are differentially labile at various storage temperatures and conditions. 9,36 Previous findings from our laboratory have demonstrated that after only 24 hours of storage at 4°C, certain serum isoenzymes can lose up to T A B L E 3 Reference intervals for serum and CSF total lactate dehydrogenase (LD) activity 14 The CSF LD isoenzyme percentages determined in our study were similar, although with slight differences: we found LD-1 was less predominate (median 40.5%), and that LD-3 and LD-5 contributed greater percentages (medians 14.8% and 11.1%, respectively).
It is important to note that CSF LD isoenzymes are more labile than those present in serum. 36, 40 This has been attributed to the low protein in CSF with subsequent lack of enzyme stabilization. 38 Therefore, CSF LD isoenzymes degrade rapidly-and at different rates-when stored, regardless of temperature. 36, 40 For this reason, all CSF samples were analyzed as quickly as possible in our study.
To our knowledge, ours is the first study to analyze LD isoenzymes in freshly collected canine CSF and to have adequate sample size to establish an appropriate RI.
As previously mentioned, human serum has a different LD isoenzyme distribution than that found in canine serum. In human serum, LD-1 and LD-2 predominate, 1 in contrast to canine serum, where LD-5 is by far the predominant isoenzyme, accounting for approximately half of the total LD value. In canine CSF, LD-1, and LD-2 account for the majority of LD activity, which is similar to the typical distribution of LD isoenzymes in human CSF. 14, 41 These species differences likely reflect variations in cellular energy metabolism between people and dogs. In general, LD-4 and LD-5 predominate in skeletal muscle and hepatic tissues, LD-1 and LD-2 predominate in aerobic tissues such as the heart.
15,42
Washizu et al and others have demonstrated that there are species-specific LD isoenzyme patterns in various cell and tissue types, indicating that species differences in nutrient metabolism may play an important role in the generation of LD isoenzyme patterns. 15, [43] [44] [45] Given these differences, some of the specific isoenzyme patterns described in human disease states may not be transferrable to veterinary medicine and warrant further investigation in veterinary patients.
A limitation of this study is the low sample size; however, due to the inherent risks associated with collection of CSF, a more conservative number of animals was deemed acceptable for the establishment of these RIs by ASVCP guidelines. This study remains the most robust, given that most previously published studies in dogs have smaller study sizes. 9, 14, 15 Thus, the RIs presented in this study are a necessary foundation for future studies elucidating the clinical usefulness of LD and its isoenzymes in veterinary species.
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